Enhancing the therapeutic efficacy of gemcitabine in bladder cancer through TGF-β1 inhibition and pluronic F-127-based microsphere delivery

Abstract Bladder cancer is prevalent and features significant recurrence and progression rates, necessitating effective treatment strategies. Gemcitabine, commonly used to treat non-muscle invasive bladder cancer (NMIBC), shows moderate efficacy and notable side effects. TGF-β, not only a key in epi...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yaoyao Xiong, Yangle Li, Lingxiao Chen, Minfeng Chen, Wei He, Lin Qi
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2025-07-01
Colección:	Journal of Biological Engineering
Materias:	Bladder cancer Gemcitabine TGF-β1 inhibitors Microsphere Drug-delivery system
Acceso en línea:	https://doi.org/10.1186/s13036-025-00535-7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!